Sarcoidosis Associated with Oxaliplatin-Based Chemotherapy for Colorectal Cancer

被引：10

作者：

Choi, Ji Hoon ^{[1
]}

Shin, Jung A. ^{[1
]}

Park, Hye Kyeong ^{[1
]}

Kim, Su Young ^{[2
]}

Jung, Hoon ^{[1
]}

Lee, Sung-Soon ^{[1
]}

Lee, Hye Ran ^{[1
]}

Koo, Hyeon-Kyoung ^{[1
]}

机构：

[1] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Goyang Si 2240, Gyeonggi Do, South Korea

[2] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Radiol, Goyang Si 2240, Gyeonggi Do, South Korea

来源：

CASE REPORTS IN ONCOLOGICAL MEDICINE | 2014年 / 2014卷

关键词：

D O I：

10.1155/2014/203027

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Acute lung injury occasionally occurs after chemotherapy, but pulmonary toxicities by oxaliplatin-based chemotherapy have rarely been identified. A 76-year-old female with rectosigmoid colon cancer presented with ongoing dyspnea after the eighth cycle of standard chemotherapy (5-fluorouracil, sodium folinic acid, and oxaliplatin: FOLFOX). Nodular consolidation progressed despite antibiotics and BAL fluid analysis was compatible with the diagnosis of sarcoidosis. Corticosteroid therapy rapidly improved the symptoms and radiographic findings. We report this first case of secondary sarcoidosis related to FOLFOX therapy with review of references.

引用

收藏

页数：6

相关论文

共 26 条

[1] Oxaliplatin-related side effects: Characteristics and management [J].

Cassidy, J ;

Misset, JL .

SEMINARS IN ONCOLOGY, 2002, 29 (05) :11-20

[2]

Costabel U., 1993, SARCOIDOSIS S1, V9, P211

[3] Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases [J].

Daien, Claire Immediato ;

Monnier, Agnes ;

Claudepierre, Pascal ;

Constantin, Arnaud ;

Eschard, Jean-Paul ;

Houvenagel, Eric ;

Samimi, Mahtab ;

Pavy, Stephan ;

Pertuiset, Edouard ;

Toussirot, Eric ;

Combe, Bernard ;

Morel, Jacques .

RHEUMATOLOGY, 2009, 48 (08) :883-886

[4]

DeDiego A, 1997, RESPIRATION, V64, P304

[5] Development of Bronchiolitis Obliterans Organizing Pneumonia With Platinum-Based Chemotherapy for Metastatic Rectal Cancer [J].

Fekrazad, M. Houman ;

Eberhardt, Steve ;

Jones, Dennie V. ;

Lee, Fa-Chyi .

CLINICAL COLORECTAL CANCER, 2010, 9 (03) :177-178

[6] Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer [J].

Gagnadoux, F ;

Roiron, C ;

Carrie, E ;

Monnier-Cholley, L ;

Lebeau, B .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (04) :388-390

[7] Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer -: Case report [J].

Garrido, Marcelo ;

O'Brien, Andres ;

Gonzalez, Sergio ;

Clavero, Jose Mignel ;

Orellana, Eric .

CHEST, 2007, 132 (06) :1997-1999

[8] Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line [J].

Grothey, A ;

Sargent, D .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9441-9442

[9] Medical progress: Sarcoidosis [J].

Iannuzzi, Michael C. ;

Rybicki, Benjamin A. ;

Teirstein, Alvin S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2153-2165

[10] Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy [J].

Joshita, Satoru ;

Shirahata, Kumiko ;

Yazaki, Yoshikazu ;

Okaniwa, Shinji ;

Nakamura, Yoshiyuki ;

Kimura, Takefumi ;

Noami, Sugiko ;

Horigome, Reiko ;

Yagi, Hikaru ;

Ito, Nobuo ;

Yamazaki, Asami ;

Akahane, Yuki ;

Umemura, Takeji ;

Yoshizawa, Kaname ;

Tanaka, Eiji ;

Ota, Masao .

HEPATOLOGY RESEARCH, 2013, 43 (07) :801-807